Melanoma, the most serious type of skin cancer, develops in the cells (melanocytes) that produce melanin – the pigment that gives skin its color. It can also occur in the eyes and, rarely, inside the body, such as in the nose or throat. Reducing exposure to UV radiation can help lower the risk of melanoma. The risk of melanoma seems to increase in people over 40, and especially in women.
Showing 1–12 of 19 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
|---|---|---|---|---|---|---|---|---|---|---|
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,022 mg |
-80°C |
07/2021 |
295,00 € |
||
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,088 mg |
-80°C |
03/2024 |
778,00 € |
||
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,044 mg |
-80°C |
07/2024 |
417,00 € |
||
CTLA-4 |
Monoclonal Antibody |
Yervoy® |
5 mg/mL |
yes |
2 mg |
-80°C |
08/2021 |
952,00 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
08/2018 |
270,00 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
10/2018 |
270,00 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2018 |
270,00 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
05/2019 |
270,00 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
01/2019 |
270,00 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
09/2020 |
540,00 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
11/2020 |
270,00 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2021 |
405,00 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2mg |
-80°C |
01/2024 |
270,00 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
07/2018 |
794,00 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
12/2018 |
794,00 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
03/2019 |
794,00 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
07/2019 |
794,00 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
yes |
2 mg |
-80°C |
04/2022 |
841,00 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
11/2022 |
841,00 € |
Let us know about your inquiry details and we’ll contact you shortly.
